1. Home
  2. GOTU vs AUTL Comparison

GOTU vs AUTL Comparison

Compare GOTU & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GOTU

Gaotu Techedu Inc.

N/A

Current Price

$2.56

Market Cap

578.2M

Sector

Real Estate

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

N/A

Current Price

$1.86

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GOTU
AUTL
Founded
2014
2014
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.2M
596.2M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
GOTU
AUTL
Price
$2.56
$1.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$3.75
★ $8.73
AVG Volume (30 Days)
475.6K
★ 1.4M
Earning Date
08-27-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $10,120,000.00
Revenue This Year
$15.28
$98.68
Revenue Next Year
$13.22
$28.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 496.00
52 Week Low
$1.40
$1.18
52 Week High
$3.35
$2.58

Technical Indicators

Market Signals
Indicator
GOTU
AUTL
Relative Strength Index (RSI) 75.07 43.44
Support Level $2.24 $1.84
Resistance Level $2.65 $1.92
Average True Range (ATR) 0.08 0.09
MACD 0.01 -0.01
Stochastic Oscillator 79.59 34.48

Price Performance

Historical Comparison
GOTU
AUTL

About GOTU Gaotu Techedu Inc.

Gaotu Techedu Inc is a technology-driven education company in China that enables lifelong learning through AI-powered solutions that cultivate interest and drive continuous growth. The Company provides AI-powered, product-led learning solutions for learners from pre-school to adulthood. By combining rare, high-caliber teaching resources with AI-enhanced tools and content, Gaotu creates engaging and effective learning experiences delivered through both online and offline channels. AI and data analytics permeate the Company's operations, adapting content and teaching methods to individual learner needs, improving efficiency, and driving sustained learning progress.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: